| abstract |
The invention relates to the field of therapeutic chemistry. It relates to new pharmaceutical compositions intended in particular for ocular application, characterized in that they contain, as active principle, at least one compound of 19-nor steroid structure, corresponding to the general formula I (CF DRAWING IN BOPI) in which Z is defined as in the description R1 represents a hydroxy, alkoxy, acyloxy or alkyl radical and R2 represents hydrogen or a lower alkyl radical in association or in admixture with an excipient or an inert, non-toxic vehicle, pharmaceutically acceptable. |